PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmelanoma
MeSH D008545 - melanoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D018326:Nevi and melanomas
0 Companies
0 Drugs
Success rate
D018358:Neuroendocrine tumors
16 Companies
7 Drugs
$
Success rate
D012878:Skin neoplasms
8 Companies
22 Drugs
$
Success rate
D008545: 
Melanoma
65 Companies
30 Drugs
$
Success rate
D008546:Experimental melanoma
0 Companies
0 Drugs
Success rate
D018327:Hutchinson's melanotic freckle
0 Companies
0 Drugs
Success rate
D018328:Amelanotic melanoma
8 Companies
1 Drug
$
Success rate
D000096142:Cutaneous malignant melanoma
0 Companies
0 Drugs
Success rate
D000098943:Uveal melanoma
1 Company
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaBleomycin Bleomycin  1996-06-01   
Docetaxel Docetaxel  2015-09-16   
Docetaxel Docetaxel Teva  2010-01-26   
Docetaxel Docetaxel Teva Pharma  2011-01-21   
Temozolomide Temozolomide Teva  2010-01-28   
Meitheal PharmaceuticalsDacarbazine Dacarbazine  1998-08-27   
Bleomycin Bleomycin  2018-04-20   
Carmustine Carmustine  2021-08-02   
Dactinomycin Dactinomycin  2020-11-13   
Docetaxel Docetaxel  2018-08-24   
IngenusCarmustine Carmustine  2022-06-21   
Docetaxel Docetaxel 2036-03-14 2022-11-22   
MylanDocetaxel Docetaxel  2023-05-11   
Docetaxel Docetaxel Mylan  2012-01-31   
Carmustine Carmustine  2023-03-03   
Rising PharmaceuticalsTemozolomide Temozolomide  2016-06-29   
RocheCobimetinib Cotellic  2015-11-20 $58.637 M Y2020 
Ribavirin, Peginterferon alfa-2a Pegasys Copegus  2004-06-04   
Interferon alfa-2a Roferon-A  1986-06-04   
Vemurafenib Zelboraf 2026-06-21 2011-08-17   
Atezolizumab Tecentriq  2017-09-20 $4,406.336 M Q4/22-Q3/23 
CiplaBleomycin Bleomycin  2019-03-11   
SandozDocetaxel Docetaxel  2011-06-29   
Temozolomide Temozolomide Sandoz  2010-03-15   
NovartisTrametinib Mekinist  2014-06-30   
Dabrafenib Tafinlar 2025-06-10 2013-05-29   
SanofiDocetaxel Taxotere  1996-05-14   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
74%
180/244
Phase 2
17%
50/286
Phase 3
55%
52/94
Approved: 33Overall Success rate: 7%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Bleomycin,
Docetaxel,
Temozolomide
Mylan
Docetaxel
Roche
Ribavirin,
Atezolizumab,
Cobimetinib,
Vemurafenib,
Peginterferon alfa-2a,
Interferon alfa-2a,
Benzocaine,
Vitamin k,
Tiragolumab,
Gilvetmab,
Aglatimagene besadenovec,
Fotemustine,
Alfacalcidol,
Acenocoumarol,
Aspartame,
Bevifimod,
Nepidermin,
Simlukafusp alfa,
Telbermin,
Retinol,
Mk3475,
RO7247669,
Bdb001,
Ro5185426
Cipla
Bleomycin
Sandoz
Nepidermin,
Mk3475
Novartis
Trametinib,
Dabrafenib,
Docusate,
Cilmostim,
Gilvetmab,
Tozadenant,
Spartalizumab,
Dovitinib,
Buparlisib,
Somatostatin,
Doconexent,
Darovasertib,
SIREMADLIN,
Sodium chloride,
Aspartame,
Bevifimod,
IERAMILIMAB,
Naporafenib,
Nazartinib,
Nepidermin,
Patupilone,
SOTRASTAURIN,
UPROSERTIB,
Lxh254,
Niz985,
WNT974,
NIR178,
Mk3475,
RAF265,
LTT462,
Kfa115,
Sti571,
Arm1,
For46,
Arm2,
Dky709,
LGK974
Sanofi
Docetaxel,
Ziv-aflibercept,
Cilmostim,
Gilvetmab,
Regramostim,
Molgramostim,
Sodium chloride,
Albinterferon alfa-2b,
ALOMFILIMAB,
Bevifimod,
FRESOLIMUMAB,
PIMASERTIB,
Polyglycolic acid,
Telbermin,
VOXTALISIB,
Retinol,
Ilx651,
Sagramostim,
MSC1936369B
Merck & Co
Pembrolizumab,
Ribavirin,
Interferon alfa-2b,
Peginterferon alfa-2b,
Temozolomide,
E-7386,
Melarsoprol,
Albumin,
Onfekafusp alfa,
Gilvetmab,
Entinostat,
Epacadostat,
Aglatimagene besadenovec,
Patritumab,
Edrecolomab,
Doconexent,
Regramostim,
Lornoxicam,
Alfacalcidol,
Tryptophan,
TIGILANOL TIGLATE,
Dapansutrile,
Pegargiminase,
Patritumab deruxtecan,
Sodium chloride,
Albinterferon alfa-2b,
Alovudine,
ALRIZOMADLIN,
Aspartame,
Bevifimod,
Doxecitine,
Edodekin alfa,
Favezelimab,
Iboctadekin,
LADIRATUZUMAB VEDOTIN,
Levoglucose,
Lotamilast,
Nepidermin,
Polyglycolic acid,
Quavonlimab,
Remetinostat,
Selicrelumab,
TAVOKINOGENE TELSEPLASMID,
Usistapide,
Vibostolimab,
Gonadotropin, chorionic,
APG115,
Mk-4280,
Deoxycytidine,
Ngm707,
Caelyx,
Doxorubin,
GEN0101,
Mk3475,
NGM438,
Imm60,
Articular,
GSK2636771,
Montanide,
Sti571,
Arm1,
ENB003,
Flt3l,
For46,
Hydroxydaunomycin,
Arm2,
MRX0518,
Darleukin,
E7389
Bayer
Dacarbazine,
Albumin,
Cilmostim,
Entinostat,
Regramostim,
Molgramostim,
Bevifimod,
Nepidermin,
SAGOPILONE,
Bay2666605,
Sagramostim,
Tisseel,
Docetaxol
Pfizer
Docetaxel,
Losartan,
Angiotensin ii,
Txa127,
Utomilumab,
Sasanlimab,
Gilvetmab,
Aglatimagene besadenovec,
Ganitumab,
Buparlisib,
Agatolimod,
ULIXERTINIB,
Sodium chloride,
Albinterferon alfa-2b,
Bevifimod,
Edodekin alfa,
Nepidermin,
Telbermin,
Tiratricol,
Ag013736,
Mk3475,
Pf03512676,
Hiltonol,
Pd0332991,
Montanide,
Antacid,
Arm1,
Wellbutrin,
Arm2,
Ro5185426
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use